Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was CNY 107.97 million compared to CNY 146.55 million a year ago. Revenue was CNY 108.91 million compared to CNY 147.07 million a year ago.

Net loss was CNY 67.56 million compared to CNY 29.8 million a year ago. Basic loss per share from continuing operations was CNY 0.55 compared to CNY 0.24 a year ago. Diluted loss per share from continuing operations was CNY 0.55 compared to CNY 0.24 a year ago.